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Open access under CC BWe previously proposed microchip-based phosphate-afﬁnity electrophoresis (lPAE) and demonstrated
its application to activity measurement of a tyrosine kinase, c-Src. In this study, we extended the lPAE
application to a serine/threonine kinase, protein kinase A (PKA), and to a tyrosine phosphatase, leukocyte
antigen-related protein tyrosine phosphatase (LAR PTPase). For standard peptide samples, we obtained
linear calibration plots, and the limits of detection were 1.2% (PKA) and 1.5% (LAR PTPase) product pep-
tides in the total peptides. The lPAE was also proven to be effective for unpuriﬁed enzyme reaction
products.
 2011 Elsevier Inc. Open access under CC BY-NC-ND license.Intracellular signaling networks are constructed on the basis of
the subtle balance between phosphorylation and dephosphoryla-
tion by protein kinases and phosphatases, respectively [1]. There
are more than 500 kinases encoded within the human genome,
with more than 200 of them implicated in diseases. Phosphatases
act in opposition to kinases and are integral to many signal trans-
duction pathways [2]. Therefore, it is important to develop tech-
niques for detecting and analyzing both kinases and phosphatases.
For this purpose, radioactive-based assays are one of the most
common techniques [3]. However, these experiments are poten-
tially hazardous. Therefore, nonradioactive assay methods are
becoming popular. Especially for peptide substrates, separation of
the phosphorylated peptide from the nonphosphorylated peptide
provides an effective way to determine the kinase or phosphatase
activity. The separation can be accomplished bymass spectrometry
[4] or capillary electrophoresis [5]. These methods are suitable for
automated high-throughput assays, but bulky and sophisticated
instruments are required. For benchtop assays with shorter analy-
sis time and smaller sample volumes, microﬂuidic chips (micro-
chips) have also been used for electrophoretic separation of the
target peptides based on the electrical charge difference [6]. The
phosphorylation-based separation is also possible with a
phosphate-speciﬁc afﬁnity ligand, Phos-tag [7]. Acrylamide-linked
Phos-tag, commercialized as Phos-tag Acrylamide, has been
copolymerized with acrylamide to make gel slabs, which were sub-.
Y-NC-ND license.sequently used for electrophoretic mobility shift assays based on
the phosphorylation [8].
Using Phos-tag Acrylamide and a poly(dimethylsiloxane)
(PDMS)1–glass microchip, we have demonstrated microchip
phosphate-afﬁnity electrophoresis (lPAE) [9]. The sample solution
contained a substrate peptide of a tyrosine kinase, c-Src, and its
phosphorylated product. The latter was trapped by Phos-tag,
whereas the former migrated. As a result, the two peptides were
baseline separated in 10 s. However, that work contained only preli-
minary results of lPAE for a serine/threonine kinase and no results
for phosphatases.
In this note, we describe applications of the lPAE to a serine/
threonine kinase, protein kinase A (PKA), and to a tyrosine phos-
phatase, leukocyte antigen-related protein tyrosine phosphatase
(LAR PTPase). PKA is involved in cell proliferation, gene induction,
angiogenesis, and apoptosis [10]. LAR PTPase is found in liver and
muscle, and it modulates insulin signaling. LAR PTPase also plays a
suppressive regulatory role in tumor growth [11].
Table 1 shows the sequences of the peptides used in this work.
The principle of lPAE is illustrated in Fig. 1A. In advance, the sample
and the polymer solutions were autonomously loaded into speciﬁc
regions of the microchannel with our original solution ﬁlling tech-
nique [12–14]. The sample contains two kinds of peptides: phos-
phorylated and nonphosphorylated. Both are ﬂuorescently labeled.1 Abbreviations used: PDMS, poly(dimethylsiloxane); lPAE, microchip phosphate-
fﬁnity electrophoresis; PDMA, poly(dimethylacrylamide); LOD, limit of detection;
TP, adenosine triphosphate.a
A
Table 1
Sequences of peptides used in this work.
Symbol Sequence Description
P1 FAM-EEELRRASLG PKA substrate
P2 FAM-EEELRRA[pS]LG PKA product
P3 FAM-DADE[pY]LIPQQG LAR PTPase substrate
P4 FAM-DADEYLIPQQG LAR PTPase product
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lized to the poly(dimethylacrylamide) (PDMA) chains. When the
peptides are electrophoresed into thepolymer region, thephosphor-
ylated peptide is trapped by the Phos-tag, whereas the nonphos-
phorylated peptide continues to migrate. As a result, the two
peptides are separated. As an example, Fig. 1B and C show a ﬂuores-
cence image and the corresponding proﬁle plot, respectively, of the
lPAE separation of an equimolarmixture of P1 and P2. The two pep-
tides are quantiﬁedwith thepeakareas. For kinase activitymeasure-
ment, the kinase sample is reacted with the nonphosphorylated
substrate peptide prior to the lPAE. In this case, the amount of the
phosphorylated product peptide, evaluated from Atrap, is correlated
with the kinase activity. For phosphatase activity measurement, on
the contrary, Amig is correlated with the phosphatase activity.
For PKA assay, we used the Kemptide sequence [15] with three
additional glutamic acid residues (P1 in Table 1). We prepared an-
other synthetic peptide P2, which is the serine-phosphorylated
form of P1. We previously found that phospho-serine has much
weaker afﬁnity to Phos-tag than that exhibited by phospho-tyro-
sine [9]. Therefore, in this set of experiments, we used a Phos-
tag–PDMA conjugate containing 10 times as much Phos-tag as
the conjugate for phospho-tyrosine (1.0 vs. 0.1 mM).
First, we assessed the effectiveness of the lPAE for PKA activity
measurement using standard samples consisting of P1 and P2 at
various molar ratios while keeping the total peptide concentration
at 10 lM. A 1.0-ll aliquot of the sample was applied to theFig.1. (A) Schematic representation of the lPAE. The phosphorylated peptide is selectiv
ﬂuorescence image (B) and proﬁle plot (C) of the lPAE with the notation of peak areas. (D)
P2 in the PKA standard samples. The error bars indicate ±1r (n = 3). (E) Normalized pea
different PKA concentrations. (F) Normalized peak area Amig at lPAE time of 10 s plotted
indicate ±1r (n = 3). (G) Normalized peak area Amig at lPAE time of 10 s plotted againstmicrochip, and the lPAE was started. The two peptides were base-
line separated in 15 s, as shown in Fig. 1B and C. We measured the
trapped peak area Atrap and the migrating peak area Amig. The de-
gree of phosphorylation is assumed to be expressed by the normal-
ized trapped peak area: Atrap = Atrap/(Atrap + Amig). In Fig. 1D, Atrap at
lPAE time of 15 s is plotted against the molar fraction of P2 in the
standard sample. The two parameters show excellent agreement,
implying that the lPAE is effective for quantifying the serine-phos-
phorylated peptide P2, which can be directly related to PKA activ-
ity. The limit of detection (LOD), based on the 3r criterion, was
calculated as 1.2% P2 in the total peptides. It is slightly worse than
the LOD that we reported for the c-Src product peptide, 0.9% [9].
However, the signiﬁcance of this difference is currently unclear.
Next, we applied the lPAE to unpuriﬁed PKA reaction products.
Recombinant PKA catalytic subunit (cat. no. P2645, Sigma) was re-
acted with 10 lM P1 in the presence of 0.10 mM adenosine tri-
phosphate (ATP). The reaction was stopped by heating. The
resulting mixture was analyzed in the same way as the standard
samples described in the previous paragraph. The degree of phos-
phorylation was evaluated by the normalized peak area Atrap at
lPAE time of 15 s. The resulting Atrap is plotted against the PKA
reaction time in Fig. 1E. As expected, the higher Atrap was obtained
by the higher PKA concentration or the longer reaction time. This
indicates that the existence of PKA or ATP did not signiﬁcantly
interfere with the binding between phospho-serine and Phos-tag.
In addition, we carried out preliminary experiments to check the
speciﬁcity of this assay using another serine/threonine kinase,
CK2, as a potential contaminant (see Supplementary material). As
a result, a very low level of cross reaction was observed.
For LAR PTPase assay, we adopted the substrate sequence P3
(Table 1) from the literature [16]. We also prepared the dephos-
phorylated form of P3 and named it P4, which corresponds to the
product of the enzyme. The same Phos-tag–PDMA conjugate as
in our previous article [9], containing 0.10 mM Phos-tag, was used
in this set of experiments because the trapping target became
phospho-tyrosine again.ely trapped by the Phos-tag immobilized to the PDMA chain. (B, C) Representative
Normalized peak area Atrap at lPAE time of 15 s plotted against the molar fraction of
k area Atrap at lPAE time of 15 s plotted against the enzymatic reaction time with
against the molar fraction of P4 in the LAR PTPase standard samples. The error bars
the enzymatic reaction time with different LAR PTPase concentrations.
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various molar ratios with the total concentration of 10 lM. The
two peptides were baseline separated in 10 s. The biggest differ-
ence between this phosphatase assay and the kinase assay is that
the enzyme activity is related to the area of the migrating peak
Amig, which reﬂects the amount of the dephosphorylated peptide.
We normalized the migrating peak area by the following equation:
Amig = Amig/(Atrap + Amig). In Fig. 1F, Amig at lPAE time of 10 s is plot-
ted against the molar fraction of P4 in the standard sample. The
data points show an excellent linear relationship. The LOD, calcu-
lated as 1.5% P4 in the total peptides, was worse than the LOD of
the c-Src standard sample (0.9% [9]) and that of the PKA standard
sample in this study (1.2%). However, the LOD of 1.5% was not as
bad as expected because we basically measured the migrating
peak, which is broader than the trapped peak measured in kinase
assays (see Fig. 1B and C). The effect of the band broadening on
the LOD was not clearly observed in this study.
Finally, we analyzed LAR PTPase reaction products with the
lPAE. The substrate peptide P3 at 10 lM was reacted with recom-
binant LAR PTPase (cat. no. L0907, Sigma), and the reaction was
stopped by heating. The resulting mixture was applied to the
microchip, and the lPAE was carried out. The progress of dephos-
phorylation was evaluated by the normalized peak area Amig at
lPAE time of 10 s. As shown in Fig. 1G, Amig increased with the
LAR PTPase concentration and the reaction time. These results indi-
cate that Amig reﬂected the progress of the LAR PTPase reaction.
In conclusion, we have demonstrated successful applications of
the lPAE method to activity measurements of a serine/threonine
kinase (PKA) and a tyrosine phosphatase (LAR PTPase). In both
cases, the assay performances were as good as that of a tyrosine ki-
nase (c-Src) that we reported previously [9]. We are currently
investigating application of the lPAE to crude cell lysates and opti-
mization of the lPAE for further improvement of the sensitivity.Acknowledgments
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